YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
3.240
-0.460 (-12.43%)
At close: Sep 17, 2026, 4:00 PM EDT
3.190
-0.050 (-1.54%)
After-hours: Sep 17, 2026, 7:30 PM EDT
YD Bio Revenue
YD Bio had revenue of $423.25K in the quarter ending June 30, 2026, with 196.62% growth. This brings the company's revenue in the last twelve months to $1.24M, up 147.92% year-over-year. In the year 2025, YD Bio had annual revenue of $596.82K with 16.94% growth.
Revenue (ttm)
$1.24M
Revenue Growth
+147.92%
P/S Ratio
183.84
Revenue / Employee
n/a
Employees
n/a
Market Cap
227.84M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 596.82K | 86.46K | 16.94% |
| Dec 31, 2024 | 510.36K | 160.23K | 45.76% |
| Dec 31, 2023 | 350.13K | -13.99K | -3.84% |
| Dec 31, 2022 | 364.12K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
YDES News
- 17 days ago - YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026 - GlobeNewsWire
- 23 days ago - YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute - GlobeNewsWire
- 7 weeks ago - YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada - GlobeNewsWire
- 1 month ago - YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - GlobeNewsWire
- 2 months ago - YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - GlobeNewsWire
- 4 months ago - YD Bio Limited Reports Full Year 2025 Financial Results - GlobeNewsWire
- 5 months ago - YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States - GlobeNewsWire
- 6 months ago - YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem - GlobeNewsWire